These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16418571)

  • 1. Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism.
    Yee KO; Connolly CM; Pines M; Lawler J
    Cancer Biol Ther; 2006 Feb; 5(2):218-24. PubMed ID: 16418571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of thrombospondin-1 on breast cancer metastasis.
    Yee KO; Connolly CM; Duquette M; Kazerounian S; Washington R; Lawler J
    Breast Cancer Res Treat; 2009 Mar; 114(1):85-96. PubMed ID: 18409060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone.
    Xavier S; Piek E; Fujii M; Javelaud D; Mauviel A; Flanders KC; Samuni AM; Felici A; Reiss M; Yarkoni S; Sowers A; Mitchell JB; Roberts AB; Russo A
    J Biol Chem; 2004 Apr; 279(15):15167-76. PubMed ID: 14732719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms.
    Miao WM; Seng WL; Duquette M; Lawler P; Laus C; Lawler J
    Cancer Res; 2001 Nov; 61(21):7830-9. PubMed ID: 11691800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.
    McGaha TL; Phelps RG; Spiera H; Bona C
    J Invest Dermatol; 2002 Mar; 118(3):461-70. PubMed ID: 11874485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
    Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
    J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
    García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta.
    Yee KO; Streit M; Hawighorst T; Detmar M; Lawler J
    Am J Pathol; 2004 Aug; 165(2):541-52. PubMed ID: 15277228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo.
    Gross DJ; Reibstein I; Weiss L; Slavin S; Dafni H; Neeman M; Pines M; Nagler A
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3788-93. PubMed ID: 14506172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling.
    Gnainsky Y; Kushnirsky Z; Bilu G; Hagai Y; Genina O; Volpin H; Bruck R; Spira G; Nagler A; Kawada N; Yoshizato K; Reinhardt DP; Libermann TA; Pines M
    Cell Tissue Res; 2007 Apr; 328(1):153-66. PubMed ID: 17180598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
    Zion O; Genin O; Kawada N; Yoshizato K; Roffe S; Nagler A; Iovanna JL; Halevy O; Pines M
    Pancreas; 2009 May; 38(4):427-35. PubMed ID: 19188864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone.
    Elkin M; Ariel I; Miao HQ; Nagler A; Pines M; de-Groot N; Hochberg A; Vlodavsky I
    Cancer Res; 1999 Aug; 59(16):4111-8. PubMed ID: 10463616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.
    McGaha TL; Kodera T; Spiera H; Stan AC; Pines M; Bona CA
    Arthritis Rheum; 2002 Oct; 46(10):2748-61. PubMed ID: 12384935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts.
    Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
    Am J Pathol; 2005 May; 166(5):1451-63. PubMed ID: 15855645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis.
    Abramovitch R; Dafni H; Neeman M; Nagler A; Pines M
    Neoplasia; 1999 Oct; 1(4):321-9. PubMed ID: 10935487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.
    Kim JH; Kim BK; Moon KC; Hong HK; Lee HS
    Kidney Int; 2003 Nov; 64(5):1715-21. PubMed ID: 14531804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
    Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
    Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.
    Lawler J
    J Cell Mol Med; 2002; 6(1):1-12. PubMed ID: 12003665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
    Kiyono K; Suzuki HI; Morishita Y; Komuro A; Iwata C; Yashiro M; Hirakawa K; Kano MR; Miyazono K
    Cancer Sci; 2009 Oct; 100(10):1809-16. PubMed ID: 19594546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model.
    Assis PA; De Figueiredo-Pontes LL; Lima AS; Leão V; Cândido LA; Pintão CT; Garcia AB; Saggioro FP; Panepucci RA; Chahud F; Nagler A; Falcão RP; Rego EM
    J Exp Clin Cancer Res; 2015 Jun; 34(1):65. PubMed ID: 26099922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.